Novel 7-deazapurine nucleosides for therapeutic uses
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F15%3A00455926" target="_blank" >RIV/61388963:_____/15:00455926 - isvavai.cz</a>
Result on the web
<a href="http://hdl.handle.net/11104/0256525" target="_blank" >http://hdl.handle.net/11104/0256525</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Novel 7-deazapurine nucleosides for therapeutic uses
Original language description
Disclosed are 7-(-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I, wherein R1, R2 and R3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of opticalisomers, as well as compositions comprising such compounds. These compounds are suitable for treating a cellular proliferation disease or a neoplastic disease or a tumor or cancer.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
CC - Organic chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
NZ596301
Publisher
NZ001 -
Publisher name
Intellectual Property Office of New Zealand (IPONZ)
Place of publication
Wellington
Publication country
NZ - NEW ZEALAND
Date of acceptance
Feb 10, 2015
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence